The Optical Revolution in Remote Blood Pressure Management
We're on a mission to reinvent remote patient biosensing through smartphone based software and other edge computing technologies.
Biospectal is making instant, ubiquitous, and accurate remote blood pressure monitoring and management a reality. By placing a finger on the smartphone camera, anyone can transform their phone into a medical grade blood pressure monitor including data integration with the clinical care regimen– any time, anywhere in the world.
Supporters
News
Biospectal Joins CSEM at Swissnex Boston and MIT to Discuss Digital Health Innovation
Biospectal joined a panel hosted by the Swiss Center for Electronics and Microtechnology (CSEM) on February 20th in Cambridge, Massachusetts to dialogue about Swiss and American perspectives on Digital Health Innovation. CSEM opened the evening
Biospectal Wins 2018 MassChallenge Gold Prize Among 1000 Competitors
We are honored to have Biospectal’s cuffless optical blood pressure solution recognized by being awarded MassChallenge Switzerland’s 2018 Gold prize from a field of 1000 applicants and many talented cohort participants. A shout out to
Biospectal Selected as One of Ten Finalists for the “Saving Lives at Birth” 2018 Grand Challenge
Biospectal was recently selected from more than five hundred applicants to present with our partner team at the Saving Lives at Birth Global Grand Challenge DEVELOPMENTxCHANGE conference in Washington, D.C. Saving Lives at Birth is focused
Biospectal to Present the Democratized Future of Biosensing at Digital Health Connect ’18
On June 15, Professor Patrick Schoettker M.D., co-founder, Senior Medical Advisor, and inspiration behind Biospectal’s breakthrough software based optical analysis in smartphones to tackle the global hypertension epidemic, will present at the Digital Health Connect conference sponsored
Biospectal One of Six Swiss Startups at CES 2018
Biospectal was honored to be chosen as one of six Swiss startups representing the next generation of Swiss innovation at this year’s CES in Las Vegas. Dr. Patrick Schoettker was blown away by the interest